Simon Lowth, Interim Chief Executive Officer at AstraZeneca, comments on the results. AZ’s core EPS target range for the full year is expected to maintain at US$5.85 to $6.15. This is largely ...

Simon Lowth, Interim Chief Executive Officer, AstraZeneca. AstraZeneca has also announced that it will be ceasing its second stage trials of CytoFab (AZD9773), after the drug, for patients with ...

Simon Lowth, chief financial officer at BT Group, said: “By integrating yet more electric vehicles into our operations, we are taking another significant step towards reducing our carbon ...

we are taking another significant step towards reducing our carbon footprint and supporting the UK’s transition to a greener future,” said Simon Lowth, Chief Financial Officer, BT Group.

The order of the new EVs is part of a larger delivery of 6,000 new vehicles, with more than half of the vans being EVs. Simon Lowth, chief financial officer at BT Group, said: “By integrating yet more ...

Simon Lowth, BT Group's chief financial officer, commented: "By integrating yet more electric vehicles into our operations, we are taking another significant step towards reducing our carbon ...

Simon Lowth, chief financial officer at BT Group, said: “By integrating yet more electric vehicles into our operations, we are taking another significant step towards reducing our carbon ...